Review of IMS Health undertakings

The Competition Commission has decided against varying or removing undertakings which restrict the way in which IMS Health Incorporated sells its specialized pharmaceutical data services.

Administrative timetable

  • Published on 18 October 2013 as required by Rule 6 of the Competition Commission Rules of Procedure. Any revisions made to the timetable will be published on this website.
Phase 2 Action
6 August 2013 OFT’s advice sent to the CC
13 September 2013 Deadline for consultation on OFT’s advice
September to November 2013 Consideration of OFT’s advice, responses to consultation and further CC assessment
December 2013 Publish provisional decision on change of circumstances and, as appropriate, a Notice of proposal to release or vary the undertakings
January 2014 Consideration of responses to provisional decision
February 2014 Publish final decision and, as appropriate, a Notice of release or variation of the undertakings

Phase 2

Date of referral: 06/08/2013

Background information

News releases

Core documents

Phase 1

IMS Health undertakings review

Affected market: Pharmaceutical Data Services **No. ME/0139/98

Report to CC

Download the OFT’s advice to the CC

Published 9 December 2014